StockData
Regen BioPharma Inc logo

Regen BioPharma Inc (RGBP) stock

RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026Market cap $92.33KP/E –Yield –

Regen BioPharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Regen BioPharma's enterprise value was $169.26K on Oct 19, 2026, against $407.35K a year earlier. Over the last 5 years it ranged from $891 to $54.16B, with a median of $1.52M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$169.26K-23.7%
2025Dec 31, 2025$221.82K-39.9%
2024Dec 31, 2024$368.94K-78.2%
2023Dec 29, 2023$1.69M-82.6%
2022Dec 30, 2022$9.76M-100.0%
2021Dec 31, 2021$47.80B+3871.0%
2020Dec 31, 2020$1.20B+1237.6%
2019Dec 31, 2019$89.99M-76.2%
2018Dec 31, 2018$378.65M-92.9%
2017Dec 29, 2017$5.34B-37.9%
2016Dec 30, 2016$8.60B-35.6%
2015Dec 31, 2015$13.34B+146.2%
2014Dec 31, 2014$5.42B–

More Regen BioPharma figures

See a number that looks wrong?